University of Dundee

Molecular Medicine

Short Code: 

GSK and CLS begin collaboration to develop therapies for rare genetic skin disorders

GlaxoSmithKline (GSK) and the College of Life Sciences at the University of Dundee have entered into an agreement to combine the pharmaceutical company’s expertise in discovering and developing new medicines with the researcher’s expertise in rare and debilitating skin disorders under GSK’s Discovery Partnerships with Academia initiative.  

Gene identified as a cause of peanut allergy

An international collaboration led by the College of Life Sciences at the University of Dundee has made a significant breakthrough in understanding the causes of peanut allergy.

Peanut allergy affects 1-2% of children in the UK and may result in a severe or life-threatening allergic reaction. The number of people affected by peanut allergy has increased dramatically over the past 20-30 years, but the causes of the disease are unknown.

New Fellows elected to the Academy of Medical Sciences

Three academics from the University of Dundee are among forty of the United Kingdom's leading doctors and medical researchers who have been recognised for excellence in medical science by their election to the Fellowship of the Academy of Medical Sciences.

Academy Fellows are elected for outstanding contributions to the advancement of medical science, for innovative application of scientific knowledge or for their conspicuous service to healthcare.

The new Fellows to be elected from Dundee are: